Archived Issue

Vol. 1 No. 4 (2026): Fourth Issue - October 2026

Volume1
Number4
Year2026
Articles7

Published Published: 2026-10-31

Issue articles

Articles Publishing terms and rules 7

Article 1
Abstract

Background: Multidrug resistance (MDR) Pseudomonas aeruginosa has become a major clinical problem because of its resistance to a variety of antibiotic classes and the limited number of effective therapy options. Objectives: This study was to perform structure-based design, molecular docking and molecular characterization of Uridine-based and Liponucleoside derivatives of essential translocase in MDR P. aeruginosa (MraY). Results : An antimicrobial resistance profile of (44) forty-four isolates of P. aeruginosa revealed high levels of resistance to, cefotaxime, amoxicillin-clavulanic acid and trimethoprim-sulfamethoxazole (100%), and 60% of strains were resistant to the carbapenems. All the clinical isolates were positive results in PCR for the presence of MraY gene, its conserved a widespread distribution, and therapeutic importance. Cavity detection and virtual screening in five possible binding pockets resulted in Cavity1 (C1) having a volume of 1819 Å3 at the coordinates (-20, -1, 14) being the main catalytic active site. The natural reference inhibitor Muraymycin C2 showed a high binding interaction of -9.6 kcal/mol within the C1, with significant interactions with the residue ASP115, ASP116, SER120 and THR73. While, the candidate ligand, Uridine 5ˈ-monophosphate, showed a stable and consistent binding score of (-7.6 kcal /mol) in C1, with supporting hydrogen bonds with ALA56, ASP116 and THR71.

ADMET and toxicological profiling indicated that Uridine 5ˈ-monophosphate possesses a favorable molecular weight (324.18 g/mol) and compliance with drug-like properties, while both evaluated ligands exhibited exceptionally clean safety profiles, showing no  mutagenicity (AMES), hepatotoxicity, cardiotoxicity (hERG) or skin sensitization risks.  Conclusions: The findings highlight that while Muraymycin C2 serves as a high-affinity natural benchmark, the uridine-based scaffold provides a non-toxic and chemically tractable framework for future lead optimization against MDR P. aeruginosa.

Keywords: Uridine 5ˈ-monophosphate, MraY translocase, Clinical isolates Multidrug-resistant Pseudomonas aeruginosa, ADMET profiling, Muraymycin C2, Structural-based drug design, Molecular docking.  

Article 2

The Role of Bioinformatics in Understanding Cancer Viruses: From Genome Sequencing to Antiviral Discovery Cancer Viruses

Zainab Abd Al_hassan Zwain, Sahar Mohammed Jawad, Emad Kareem Alsabari, Alaa Mohammed Khaleel, Dhefaf Hameed Al-Mudhafar, Hasanain Ali Shubbar, Sara salih hassan, Dr. Samer A. MH. Al-Hilali, Eman Hassani Shabat, Tabarek Hadi Al-Naqeeb, Liqaa Hadi Naser, Ayat Raad jawad, Saif Jabbar Yasir (Author)

Abstract

Background: Virus-associated cancers are caused by several oncogenic mechanisms such as direct oncoprotein expression, chronic inflammation and viral genome integration, and are responsible for a substantial part of the global cancer burden. High-throughput sequencing has revolutionized tumor virology research, but studying viral-host interactions remains computationally and methodologically challenging because host genomes are repetitive, sequencing error rates are high, and samples are contaminated. Objectives: This review aims to integrate existing computational and sequencing approaches in cancer virology and to emphasize the importance of bioinformatics in bridging the gap between the raw genomic data and the identification of viral biomarkers and anti-viral targets. Methodological and Technological Framework: We assess the joint performance of state-of-the-art bioinformatic pipelines (e.g. VIRUS Breakend, nf-VIF, Exogene), target-enrichment capture methods and short- and long-read sequencing systems (e.g. PacBio HiFi and Oxford Nanopore). We are focusing on the integration of passenger event drivers, intrahost viral diversity assessment, and microbial detection resolution for low-biomass tumor samples. Key Points: Long read sequencing has revolutionized the mapping of integration sites, resolving full-length virus-host junctions and complex structural rearrangements. Integration of multi-omic data including transcriptomics, chromatin conformation data and variant analysis is also key to understand how viral insertions disrupt host regulatory neighborhoods and drive oncogene expression, e.g. E6/E7 in HPV-associated cancers. But reproducibility needs orthogonal validation, contamination filtering, and strict quality control. Conclusion: Advanced bioinformatic frameworks are the answer for mapping viral integration landscapes and tracking intrahost evolution. These computational insights will need to be prospectively validated in clinical cohorts with standardized reporting to translate them into actionable prognostic markers and standard treatments.

Article 3
Abstract

Background: With the growing concern over the effects of global warming on agriculture in regions where temperatures are high and the quality of the soil is low, there is an ever-greater need for us to find ways to increase the efficiency of producing food. Tomatoes, for example, are greatly affected by both temperature and soil quality. Aim of study: Therefore, the overall purpose of this research project is to examine whether the application of both organic and inorganic fertilizers can improve the quality of the soil and therefore increase the productivity of tomato plants as they undergo heat stress. Methodology: Tomato plants were treated with different mixtures of organic and inorganic fertilizers. Organic fertilizer alone was used, as well as in combination with other types of fertilizers to provide a sufficient quantity of fertilizer for the individual treatments depending on their particular characteristics. The effects of the treatments on the tomato plants and the soil were evaluated using experimental designs that were suitable for the current environmental conditions. The assessment considered the soil's physical and chemical properties, including organic matter content, saturated hydraulic conductivity at field capacity, and electrical conductivity. Additionally, it examined several plant characteristics, such as plant height, the fruit count per plant, and the total fruit weight. Results: The application of both organic and inorganic fertilizers has significantly improved soil structure and water-holding capacity as compared with the application of either organic or inorganic fertilizers alone. Also, organic and inorganic fertilizers have reduced the negative impacts of heat stress on tomato plants and increased both vegetative and reproductive growth in tomato plants. Lastly, organic and inorganic fertilizers have increased the use of nutrients in tomato plants while reducing the loss of nutrients from the soil. Therefore, organic and inorganic fertilizers can provide a means to increase sustainability in agriculture. Conclusions: The results suggest that it is possible to produce consistently high-quality tomatoes over time by combining organic and inorganic fertilizers (as a different approach) as a method for producing consistently high-quality tomatoes over time, while maintaining a sustainable approach. This research supports the growing trend of combining organic and inorganic fertilizers as a realistic way to achieve sustained increases in soil fertility and thus possibly provide positive outcomes for food security.

Article 4
Abstract

Background: The rising incidence of multidrug-resistant (MDR) Gram-negative bacteria, particularly Klebsiella pneumoniae and Acinetobacter baumannii, constitutes a significant public health threat worldwide. The occurrence of resistance-associated genes, such as blaNDM and blaOXA-23, and virulence-associated determinants, such as kfu, underscores the necessity for research into alternative antibacterial agents. One of the botanical sources of secondary metabolites that have been reported to have antimicrobial properties was the plant Ficus benjamina L. Objective: The present study intends to evaluate the antibacterial potential and phytochemical constituents of Ficus benjamina leaf extracts against MDR K. pneumoniae and A. baumannii with special emphasis on molecular characterization of resistance and virulence-associated genes and their possible correlation with bacterial susceptibility. Materials and Methods: An experimental model was consisted of 60 bacterial isolates, 30 isolates of K. pneumoniae and 30 isolates of A. baumannii. The included phytochemical screening, molecular characterization of blaNDM, blaOXA-23, and kfu, and antibacterial susceptibility assessment by agar diffusion and broth microdilution. Three extract concentrations were studied (25, 50 and 100 mg/mL). Results: The model illustrated a concentration-associated increase in antibacterial inhibition. At 100 mg/mL, the mean inhibition-zone diameters were 15.3 ± 2.1 mm for K. pneumoniae and 12.7 ± 1.9 mm for A. baumannii. the median minimum inhibitory concentrations were 25 mg/mL and 50 mg/mL. molecular-marker positivity for A. baumannii isolates was 70% for blaOXA-23, 40% for blaNDM and 60% for kfu in K. pneumoniae isolates. Conclusions: There was evidence that warrants furt her investigation into the antibacterial activities and phytochemical diversity of F. benjamina. The integrated approach described here might make clear the connections between molecular resistance or virulence properties, bacterial susceptibility and extract composition.

 

Article 5

Smoking Status and Tobacco-Associated Cancer Site Profiles: A Multivariable Case-Case Analysis of Oncology Registry Records in Iraq Case-Case Analysis of Oncology Registry

Dhefaf Hameed Al-Mudhafar, Sahar Mohammed Jawad, Emad Kareem Alsabari, Alaa Mohammed Khaleel, Hasanain Ali Shubbar, Sara salih hassan, Dr. Samer A. MH. Al-Hilali, Eman Hassani Shabat, Tabarek Hadi Al-Naqeeb, Zainab Abd Al_hassan Zwain, Liqaa Hadi Naser, Ayat Raad jawad, Saif Jabbar Yasir (Author)

Abstract

Background: Tobacco smoking has been associated with a number of malignancies including the lung, larynx and urinary bladder. However, the smoking status patterns reported by Iraqi oncology registries are not properly characterized at the site-specific level. Hospital-based case–case analyzes may not be able to establish population-level cancer risks but they may offer useful insights into these patterns. Objective: To investigate the associations between relative representation of lung, laryngeal and urinary bladder cancers in the records of oncology registry in Iraq, after controlling for age, sex and registration year, and documented current and former smoking. Methods: We conducted a retrospective registry-based case-control study using five annual oncology datasets from 2022 to 2026. To be eligible, the records must have included a diagnosis of a recognizable malignant neoplasm (ICD-10 C00–C97), an interpretable age and sex, and a documented smoking status. Smoking was classified as current, former, or documented nonsmoking. Lung (C34), laryngeal (C32) and urinary bladder (C67) cancers were compared with other registered malignancies in separate multivariable logistic regression models, adjusted for age, sex and registration year. Six major smoking-cancer associations were evaluated. Benjamini–Hochberg procedure was selected for multiple testing correction. Sensitivity analyzes excluded records from 2026 and secondary analyzes estimated current or former smoking combined. Results: The reported analytical cohort included 11,664 eligible registry records, of which 2,092 (17.9%) current smokers, 1,518 (13.0%) former smokers, and 8,054 (69.1%) recorded nonsmokers. Current or previous smoking was recorded in 74.4% of lung cancer, 82.8% of laryngeal cancer and 66.5% of urinary bladder cancer records. Current smokers had higher adjusted odds of lung cancer (aOR 6.72; 95% CI 5.64-8.01), laryngeal cancer (aOR 9.81; 95% CI 6.13-15.71) and urinary bladder cancer (aOR 2.71; 95% CI 2.18-3.36) than recorded nonsmokers. Corresponding estimates for ex-smokers were 4.68 (95% CI 3.87-5.67), 9.06 (95% CI 5.47-14.99), and 2.12 (95% CI 1.67-2.69). The source analysis, corrected for multiple-testing, demonstrated statistically significant associations. Positive associations for lung and laryngeal cancers were retained in restricted-period analyzes, but a stable restricted-period bladder cancer estimate was not available. Conclusions: The relative percentages of lung, laryngeal and urinary bladder cancer diagnoses in this institutional oncology registry were associated with documented current and former smoking. These results are consistent with what is already known about tobacco-related cancers, but they should be interpreted as associations in individual cases, rather than as estimates of the risk of cancer in the population. Better documentation of smoking, identification of patients and validation of registry data is essential to reinforce future oncology research in Iraq.

Article 6
Abstract

Background: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder associated with metabolic imbalances and chronic inflammation. Interleukin-33 (IL-33) has been suggested as a biomarker for inflammation in a number of diseases. Aim of this study: To assess serum IL-33 levels in women with PCOS compared to healthy controls and to analyze its predictive capabilities as diagnostic marker for PCOS. Materials and Methods: A total of 180 women participated aged (18-40) years in the study included   90 newly diagnosed with PCOS and 90 healthy control groups in a case-control study. Serum IL-33 level was measured using an enzyme-linked immunosorbent assay. Clinical parameters such as BMI, fasting insulin (FIN) and homeostasis model assessment of insulin resistance (HOMA-IR) were measured. Besides IL-33 levels, clinical parameters such as LH, FSH, total testosterone and estradiol were also measured, and significant differences and correlations were obtained, which were all suggestive of metabolic and reproductive dysfunction associated with PCOS. The Receiver Operating Characteristic (ROC) curve analysis was used to determine the diagnostic value of IL-33 levels, and Random Forest and Support Vector Machine (SVM) classifiers were used to see how well the levels of IL-33 could predict the disease. Results: The level of serum IL-33 was found to be significantly elevated in women with PCOS (75.4 ± 12.8 pg/mL) when compared with healthy controls (34.6 ± 8.5 pg/mL, p < 0.001).  Positive correlations were observed between IL-33 level and BMI (r = 0.681,p<0.001 ), fasting insulin (r = 0.575, p<0.001), HOMA-IR (r = 0.752, p<0.001), LH (r = 0.493,p<0.001), FSH (r = 0.431,p = 0.005), LH/FSH Ratio (r = 0.484,p<0.001), Total Testosterone (r = 0.309,p<0.001), Free Testosterone (r = 0.526, p<0.001), Prolactin (r = 0.250,p = 0.062), Progesterone (r = 0.423,p = 0.007), Estradiol (E2) (r = 0.397,p<0.001) and Sex hormone binding globulin (SHBG) (r =-0.506,p<0.001) in women with PCOS group. ROC analysis was performed and resulted in an outstanding AUC value of 0.962 (95% CI: 0.934–0.990), which demonstrates excellent discrimination between PCOS and healthy subjects, with an optimal cut-off value of > 50.91 pg/mL, a sensitivity of 91.1% and a specificity of 90.0%. Conclusions: Overall, this study indicates a significant association between increased serum IL-33 levels and the inflammatory and metabolic changes seen in women with PCOS. Overall, these results highlight the promising potential of IL-33 as a valuable biomarker in the context of metainflammation in PCOS, given the high AUC values and the effectiveness of the machine learning models. These findings may have important implications for improving the diagnosis and management of PCOS and its associated complications.

Article 7

Advances and Prospects in Next-Generation CRISPR-Based Cancer Diagnostics CRISPR

Sahar Mohammed Jawad, Emad Kareem Alsabari, Alaa Mohammed Khaleel3, Dhefaf Hameed Al-Mudhafar, Hasanain Ali Shubbar, Sara salih hassan, Dr. Samer A. MH. Al-Hilali, Eman Hassani Shabat, Tabarek Hadi Al-Naqeeb, Liqaa Hadi Naser, Zainab Abd Al_hassan Zwain, Ayat Raad jawad, Saif Jabbar Yasir (Author)

Abstract

The development of CRISPR-based diagnostic technologies has created new opportunities for the sensitive and programmable detection of cancer-associated nucleic acids. By coupling guide-RNA-directed target recognition with collateral cleavage by Cas12 or Cas13 effectors, these platforms convert specific molecular interactions into fluorescent, colorimetric, electrochemical, or lateral-flow signals. When combined with target pre-amplification strategies, CRISPR assays may detect low-abundance mutations and RNA biomarkers in liquid-biopsy specimens. This review provides a concise overview of the molecular principles of CRISPR diagnostics, target recognition mechanisms, amplification strategies and emergent assay formats, with a particular emphasis on Cas12- and Cas13-based systems. Includes the applications of circulating tumor DNA, microRNAs, extracellular vesicles, early detection, tumor profiling, and treatment monitoring. Besides the analytical, pre-analytical, regulatory and implementation barriers currently limiting clinical translation, integrated microfluidic and point-of-care platforms are also discussed. The analytical performance described is promising, but many of the cancer-related assays are still at the proof-of-concept stage and require validation in larger prospective, multicenter cohorts. Before CRISPR-based tests can be used as routine diagnostics, standardized sample processing, reference materials, reproducible assay design and comparisons with established clinical methods will be imperative.

Keywords: cancer diagnostics; circulating tumor DNA; CRISPR-Cas; microRNA; liquid biopsy; Cas12a; Cas13; extracellular vesicles